Uptrend on the daily chart: above its 200-day average, below its 50-day · 50-day above the 200-day · SuperTrend up since Aug 7 · above the Ichimoku cloud · RSI 44 · MACD below its signal
None of the 29 investors followed here reported a position in SENS in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SENS trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Roeder Douglas ADirector | Stock Award(Grant) at price 9.96 per share. | 1.5K | $14.74K |
| Sep 30, 2026 | Prince Douglas SDirector | Stock Award(Grant) at price 9.96 per share. | 815 | $8.12K |
| Sep 30, 2026 | Fiorentino Edward JDirector | Stock Award(Grant) at price 9.96 per share. | 1.4K | $14.12K |
| Sep 30, 2026 | Steven Edelman VictorDirector | Stock Award(Grant) at price 9.96 per share. | 1.3K | $12.87K |
| Aug 18, 2026 | Roeder Douglas ADirector | Purchase at price 8.98 per share. | 14K | $125.30K |
| Jun 30, 2026 | Roeder Douglas ADirector | Stock Award(Grant) at price 5.36 per share. | 2.8K | $14.74K |
| Jun 30, 2026 | Prince Douglas SDirector | Stock Award(Grant) at price 5.36 per share. | 1.5K | $8.12K |
| Jun 30, 2026 | Fiorentino Edward JDirector | Stock Award(Grant) at price 5.36 per share. | 2.6K | $14.12K |
| Jun 30, 2026 | Steven Edelman VictorDirector | Stock Award(Grant) at price 5.36 per share. | 2.4K | $12.88K |
| May 20, 2026 | Fiorentino Edward JDirector | Stock Award(Grant) at price 0.00 per share. | 9.9K | — |
| May 19, 2026 | Prince Douglas SDirector | Stock Award(Grant) at price 0.00 per share. | 9.9K | — |
| May 19, 2026 | Defalco Stephen PaulDirector | Stock Award(Grant) at price 0.00 per share. | 9.9K | — |
| May 19, 2026 | Roeder Douglas ADirector | Stock Award(Grant) at price 0.00 per share. | 9.9K | — |
| May 19, 2026 | Steven Edelman VictorDirector | Stock Award(Grant) at price 0.00 per share. | 9.9K | — |
| May 19, 2026 | Larkin Sharon DeniseDirector | Stock Award(Grant) at price 0.00 per share. | 9.9K | — |
| May 18, 2026 | Jain MukulChief Operating Officer | Stock Award(Grant) at price 0.00 per share. | 270.8K | — |
| May 18, 2026 | Goodnow Timothy ToddChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 553.7K | — |
| May 18, 2026 | Hansen Brian BOfficer and Director | Stock Award(Grant) at price 0.00 per share. | 90.3K | — |
| May 18, 2026 | Horton Kenneth LGeneral Counsel | Stock Award(Grant) at price 0.00 per share. | 157.9K | — |
| May 18, 2026 | Kaufman FrancineOfficer and Director | Stock Award(Grant) at price 0.00 per share. | 63.2K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 32.8 | 12.8 | -19.5 | -0.8 | 2.7 | -16.3 | -11.4 | 83.5 | 10.2 | -12.3 | +61.6% | ||
| 2025 | 83.7 | -11.6 | -22.8 | 13.6 | -29.7 | -9.2 | 1.9 | -5.2 | -5.2 | -19.2 | -12.3 | -10.7 | −47.2% |
| 2024 | -1.4 | 24.9 | -24.4 | -8.3 | -11.7 | -7.2 | 6.3 | -8.3 | -10.0 | -3.4 | -8.0 | 68.2 | −8.2% |
| 2023 | 9.7 | -8.0 | -31.7 | -16.2 | 7.6 | 19.2 | 18.7 | -43.9 | 18.9 | -18.2 | 19.4 | -3.4 | −44.7% |
| 2022 | 0.4 | -32.8 | 9.4 | -28.9 | -17.1 | -11.2 | 25.2 | 38.0 | -25.8 | -10.6 | -5.9 | -7.2 | −61.4% |
| 2021 | 171.8 | 44.3 | -22.8 | -19.7 | -2.8 | 86.4 | -20.1 | 30.6 | -15.5 | 3.2 | -10.3 | -15.0 | +206.2% |
| 2020 | -10.7 | 71.1 | -54.7 | -10.1 | -18.1 | -16.5 | 22.6 | -1.7 | -17.7 | -3.6 | -0.8 | 135.7 | −4.8% |
| 2019 | -3.1 | 19.1 | -18.1 | -4.9 | -15.0 | 3.0 | -45.6 | -8.1 | -3.0 | 18.3 | -11.1 | -11.9 | −64.6% |
| 2018 | 0.8 | 7.8 | 3.8 | 3.0 | 7.4 | 23.8 | -10.5 | 10.9 | 16.9 | -22.2 | -8.4 | -23.8 | −2.6% |
| 2017 | 4.1 | -15.5 | -23.8 | -5.6 | -17.2 | 28.6 | 37.8 | 23.8 | 3.9 | -8.5 | 0.7 | -9.5 | −0.4% |
| 2016 | 1.5 | 0.0 | -13.3 | 20.3 | 11.0 | 2.9 | -15.5 | 20.5 | -2.5 | -40.0 | 22.2 | -6.6 | −17.8% |
| 2015 | — |
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Buy / hold / sell counts